First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age

The recruitment status of this study is unknown because the information has not been verified recently.
Verified June 2012 by University of Nebraska.
Recruitment status was  Recruiting
Sponsor:
Information provided by (Responsible Party):
University of Nebraska
ClinicalTrials.gov Identifier:
NCT01365884
First received: June 1, 2011
Last updated: June 13, 2012
Last verified: June 2012
  Purpose

Proof of concept study to compare the best corrected visual acuity obtained via First-Sight lenses with the autorefraction in children.


Condition
Refractive Error

Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Prospective
Official Title: Proof of Concept Study for First-Sight Refractive Error Correction: Direct Comparison to Autorefraction Results in Children 7 to 18 Years of Age

Resource links provided by NLM:


Further study details as provided by University of Nebraska:

Estimated Enrollment: 40
Study Start Date: June 2011
Estimated Study Completion Date: December 2012
Estimated Primary Completion Date: December 2012 (Final data collection date for primary outcome measure)
Detailed Description:

Uncorrected refractive error is a frequent cause of visual impairment in children most prevalent in rural or underserved areas in the global population. In 2006, the World Health Organization released global estimates on visual impairment. According to their findings, there are approximately 314 million people in the world whose vision is impaired. Of this population 90% of those individuals live in developing countries and 153 million cases are believed to be due to uncorrected refractive error. Children, ages five to 15 years, suffer from refractive errors (mostly myopia, hyperopia, and astigmatism) that can be improved to normal vision. It is estimated that by 2020, approximately one third of the world's population (2.5 billion) will be affected by myopia alone14. The prevalence of refractive error in school-aged children is significant especially the impact on a child's life in terms of education and development.

Studies in Western populations have collectively shown that myopia occurs <5% in children 8 years and younger. Sampling studies in other countries worldwide have shown that there is higher prevalence of myopia among Southeast Asia children and less among Australian children.1-11 Refractive error study in Eastern Nepal found 2.9% of children had vision of 20/40 or worse of which 56% of the 200 eyes tested was caused by refractive error due to myopia, hyperopia and astigmatism.12

The challenge is to determine the most effective and accessible method of detecting refractive error and dispensing spectacles for better vision. Children who have access to clinical setting typically receive prescriptive spectacles to correct refractive errors. However, in underserved areas where standard eye care may be absent, children are unable to receive the benefits of normal or near normal vision. The challenge is to determine the most effective and accessible method of detecting refractive error and dispensing spectacles for better vision

In the clinical setting, refractive error is corrected by prescribing spectacles or contact lenses on a daily basis. Typically the patient will first undergo autorefraction, in which a computer-controlled machine objectively calculates the refractive error present as a starting point for the subjective refraction test. This machine, however, is cumbersome and not easily transportable abroad. Typically the machine is held up to the patient's forehead and they are asked to look into the machine at a distant object. While they are looking at this object the machine calculates the refractive error.

First-Sight is a simplified way to correct refractive error. It is easily portable, making it accessible to remote areas of the world. Unlike the study cited above, First-Sight can be taken to remote areas where clinics are not available and patients are not able to afford to pay for the clinic visit. As it is a simplified technique, local health care workers may easily be able to learn how to use First-Sight and dispense spectacles to those in need. Lastly, sponsors of First-Sight will provide the refracting kit and dispense custom-made spectacles at no cost to health care workers and children respectively.

  Eligibility

Ages Eligible for Study:   7 Years to 18 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Population with refractive error between -4.50 to +4.50 diopter spherical error and astigmatism up to -1.50 diopters.

Criteria

Inclusion Criteria:

  1. Subjects are between 7 to 18 years of age.
  2. Healthy subjects
  3. A refractive error of -4.50 to +4.50 diopter spherical error and astigmatism up to -1.50 diopters on manifest refraction and autorefraction as documented in their medical records.
  4. Best corrected visual acuity (BCVA) of 20/20 with cycloplegic refraction.
  5. No known ocular pathology from previous clinical exams that may limit best corrected visual acuity.

Exclusion Criteria:

  1. Refractive error greater than -4.50 or +4.50 diopter, or astigmatism greater than -1.50 diopters.
  2. Known ocular (corneal, lenticular, vitreal, or retinal) pathology that may limit BCVA.
  3. Best corrected visual acuity with spectacles of 20/25 or worse.
  4. Any previous surgical or laser procedures that may limit BCVA
  5. Narrow angles of the eyes
  6. Adults, 19 years or older
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01365884

Contacts
Contact: Michael Feilmeier, MD 402-552-2020 mike.feilmeier@yahoo.com
Contact: Donna G Neely, MBA 402-559-5706 dneely@unmc.edu

Locations
United States, Nebraska
University of Nebraska Medical Center, Department of Ophthalmology Not yet recruiting
Omaha, Nebraska, United States, 68198-5540
Contact: Michael Feilmeier, MD    402-552-2020    mike.feilmeier@yahoo.com   
Contact: Donna G Neely, MBA    402-559-5706    dneely@unmc.edu   
Sub-Investigator: Sarah Wierda, MD         
Sub-Investigator: Shane Havens, MD         
Sub-Investigator: Thomas W Hejkal, MD         
University of Nebraska Medical Center Recruiting
Omaha, Nebraska, United States, 68198
Contact: Michael Feilmeier, MD    402-552-2020      
Contact: Donna Neely, MBA    402-559-5706    dneely@unmc.edu   
Principal Investigator: Michael Feilmeier, MD         
Sponsors and Collaborators
University of Nebraska
Investigators
Principal Investigator: Michael Feilmeier, MD University of Nebraska Medical Center, Department of Ophthalmology and Visual Sciences
  More Information

No publications provided

Responsible Party: University of Nebraska
ClinicalTrials.gov Identifier: NCT01365884     History of Changes
Other Study ID Numbers: 201-11-FB
Study First Received: June 1, 2011
Last Updated: June 13, 2012
Health Authority: United States: Institutional Review Board

Additional relevant MeSH terms:
Refractive Errors
Eye Diseases

ClinicalTrials.gov processed this record on October 19, 2014